Stock listing

NASDAQ:MDVN Medivation Inc Stock

Follow Medivation Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MDVN

$81.44 USD

Close on Sep 27, 2016 · No longer trades

Sep 16, 2015 to last close +63.3% · daily closes, Sep 16, 2015 – Sep 27, 2016
Lowest – highest close
$27.32 – $81.44 USDSince Sep 16, 2015 · lowest Feb 8, 2016 · highest Sep 27, 2016

Delisted NASDAQ:MDVN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MDVN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Medivation Inc on 6ix

Decks
6 decks · latest Jul 6, 2016

Decks

DeckKindSlidesDate
Investor Presentation (July 2016)Investor deck57 slidesJul 6, 2016
Merger or Acquisition (June 2016)Merger or acquisition49 slidesJun 6, 2016
Merger or Acquisition (May 2016)Merger or acquisition45 slidesMay 9, 2016
Merger or Acquisition (May 2016)Merger or acquisition41 slidesMay 6, 2016
Q1 2016 Earnings PresentationEarnings17 slidesMay 6, 2016
JP Morgan Healthcare Conference 2016Conference42 slidesJan 11, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Patrick Machado
Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past)
Director · Jun 5, 2007 – Sep 28, 2016 · Past
Dawn Svoronos
Other companies: Adverum Biotechnologies Inc (Director · Since at least Dec 9, 2020); Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past)
Director · Apr 22, 2013 – Sep 28, 2016 · Past
Joseph M. Lobacki
Other companies: Sutro Biopharma, Inc. (Member, Board of Directors · Since at least Sep 26, 2018); Verastem, Inc. (Executive VP & CCO · Jan 3, 2018 – Jan 3, 2019 · Past); Celator Pharmaceuticals Inc (Director · Dec 18, 2013 – Jul 12, 2016 · Past)
Chief Commercial Officer · Dec 8, 2014 – Jan 4, 2016 · Past
Stephen Michael Kelsey
Other companies: Revolution Medicines, Inc. (See Remarks · Since at least Feb 12, 2020); Jiya Acquisition Corp (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Geron Corporation (EVP, R&D, Chief Med Officer · Apr 27, 2009 – May 3, 2013 · Past)
SVP of New Projects · May 13, 2013 – Feb 18, 2014 · Past
Mohammad Hirmand
Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Turning Point Therapeutics Inc (EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past)
Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Medivation Inc.